FDA Inspection
AACE Pharmaceuticals, Inc.AACE Pharmaceuticals, Inc. – FDA Inspection, Aug 10, 2020
Record Details
This FDA Inspection record concerns AACE Pharmaceuticals, Inc., with an inspection on August 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AACE Pharmaceuticals, Inc.
- Inspection Date
- August 10, 2020
- Product Type
- Drugs
View Company Profile
ID · 4fcea916-b4c8-4c38-923c-6b7d75b3068a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1126698
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.194(a)(4)Complete Test Data
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AACE Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2024 | OAI | New Jersey District Office | Drug Quality Assurance |
Other documents for AACE Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.